De Clercq E - Search Results

1

Antiadenovirus activities of several classes of nucleoside and nucleotide analogues.

Naesens L, Lenaerts L, Andrei G, Snoeck R, Van Beers D, Holy A, Balzarini J, De Clercq E. Naesens L, et al. Among authors: de clercq e. Antimicrob Agents Chemother. 2005 Mar;49(3):1010-6. doi: 10.1128/AAC.49.3.1010-1016.2005. Antimicrob Agents Chemother. 2005. PMID: 15728896 Free PMC article.

2

A mercapto analogue of 5'-noraristeromycin.

Das SR, Schneller SW, Balzarini J, De Clercq E. Das SR, et al. Among authors: de clercq e. Bioorg Med Chem. 2002 Feb;10(2):457-60. doi: 10.1016/s0968-0896(01)00271-1. Bioorg Med Chem. 2002. PMID: 11741794

3

Anti-angiogenic activity of a novel multi-substrate analogue inhibitor of thymidine phosphorylase.

Liekens S, Bilsen F, De Clercq E, Priego EM, Camarasa MJ, Pérez-Pérez MJ, Balzarini J. Liekens S, et al. Among authors: de clercq e. FEBS Lett. 2002 Jan 2;510(1-2):83-8. doi: 10.1016/s0014-5793(01)03233-1. FEBS Lett. 2002. PMID: 11755536 Free article.

4

Specific recognition of the bicyclic pyrimidine nucleoside analogs, a new class of highly potent and selective inhibitors of varicella-zoster virus (VZV), by the VZV-encoded thymidine kinase.

Sienaert R, Naesens L, Brancale A, De Clercq E, McGuigan C, Balzarini J. Sienaert R, et al. Among authors: de clercq e. Mol Pharmacol. 2002 Feb;61(2):249-54. doi: 10.1124/mol.61.2.249. Mol Pharmacol. 2002. PMID: 11809847

5

Chimeric human immunodeficiency virus type 1 and feline immunodeficiency virus reverse transcriptases: role of the subunits in resistance/sensitivity to non-nucleoside reverse transcriptase inhibitors.

Auwerx J, North TW, Preston BD, Klarmann GJ, De Clercq E, Balzarini J. Auwerx J, et al. Among authors: de clercq e. Mol Pharmacol. 2002 Feb;61(2):400-6. doi: 10.1124/mol.61.2.400. Mol Pharmacol. 2002. PMID: 11809865

6

Influence of 2-substituent on the activity of imidazo[1,2-a] pyridine derivatives against human cytomegalovirus.

Mavel S, Renou JL, Galtier C, Allouchi H, Snoeck R, Andrei G, De Clercq E, Balzarini J, Gueiffier A. Mavel S, et al. Among authors: de clercq e. Bioorg Med Chem. 2002 Apr;10(4):941-6. doi: 10.1016/s0968-0896(01)00347-9. Bioorg Med Chem. 2002. PMID: 11836102

7

Antiproliferative and apoptotic effects of iron chelators on human cervical carcinoma cells.

Simonart T, Boelaert JR, Mosselmans R, Andrei G, Noel JC, De Clercq E, Snoeck R. Simonart T, et al. Among authors: de clercq e. Gynecol Oncol. 2002 Apr;85(1):95-102. doi: 10.1006/gyno.2001.6570. Gynecol Oncol. 2002. PMID: 11925126

8

6-[2-(Phosphonomethoxy)alkoxy]pyrimidines with antiviral activity.

Holý A, Votruba I, Masojídková M, Andrei G, Snoeck R, Naesens L, De Clercq E, Balzarini J. Holý A, et al. Among authors: de clercq e. J Med Chem. 2002 Apr 25;45(9):1918-29. doi: 10.1021/jm011095y. J Med Chem. 2002. PMID: 11960502

9

Lack of susceptibility of bicyclic nucleoside analogs, highly potent inhibitors of varicella-zoster virus, to the catabolic action of thymidine phosphorylase and dihydropyrimidine dehydrogenase.

Balzarini J, Sienaert R, Liekens S, Van Kuilenburg A, Carangio A, Esnouf R, De Clercq E, McGuigan C. Balzarini J, et al. Among authors: de clercq e. Mol Pharmacol. 2002 May;61(5):1140-5. doi: 10.1124/mol.61.5.1140. Mol Pharmacol. 2002. PMID: 11961132

10

New treatments for genital herpes.

Snoeck R, De Clercq E. Snoeck R, et al. Among authors: de clercq e. Curr Opin Infect Dis. 2002 Feb;15(1):49-55. doi: 10.1097/00001432-200202000-00009. Curr Opin Infect Dis. 2002. PMID: 11964906 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,293 results

Search Page

Filters